Condition 1: Kidney stone larger than 2 centimeters. Condition 2: Extracorporeal Shock Wave Lithotripsy (ESWL)-resistant kidney stones. Condition 3: Minor calyces stones larger than 1 centimeter and upper ureter stones larger than 1 centimeter. Condition 4: Cystine stones stone size with 1.5 centimeter. Calculus of kidney with calculus of ureter Calculus of kidney Calculus of lower urinary tract, unspecified Calculus in urethra
Conditions
Interventions
Intervention 1: Control group: People who undergo kidney stone surgery through the skin due to kidney stones (the standard practice of percutaneous nephrolithotomy, PCNL) are examined.If the surgery f
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: The patients who have kidney stone and are eligible for percoutaneous nephrolithotomy (PCNL) surgery 18 Age and above Being in the (American Society of Anesthesiologists 1,2) ASA 1,2 group for anesthetic risk
Exclusion criteria
Exclusion criteria: Patients with stones in the kidney have anatomical anomalies (malformation, pelvic kidney, horseshoe kidney) With BMI more than 30 Untreated coagulation disorder Taking aspirin during last 7 days Taking (Nonsteroidal Anti-inflammatory Drug) NSAID drugs during last 5 days Untreated urinary tract infection Severe pulmonary disease or other conditions that, according to an anesthetist, may not be pressure on the ipsilateral abdomen.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Access place. Timepoint: Before starting the intervention. Method of measurement: Radiography.;Kidney stone size. Timepoint: Before the intervention begins, multiply the largest diameter in the width of the stone. Method of measurement: Spiral CT abdomen and pelvis.;Experience of open kidney stone surgery. Timepoint: A day before starting the intervention. Method of measurement: Questionnaire and medical evidence.;Experience of percoutaneous nephrolithotomy surgery. Timepoint: A day before starting intervention. Method of measurement: Medical evidence and questionnaire.;Diabetic. Timepoint: A day before the intervention. Method of measurement: Medical evidence.;Patient weight. Timepoint: A day before the intervention. Method of measurement: Questionnaire.;Height. Timepoint: A day before the intervention. Method of measurement: Questionnaire.;Medicine consumption. Timepoint: A day before the intervention. Method of measurement: Questionnaire.;Gender (male, female). Timepoint: A day before the intervention. Method of measurement: Questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of surgery. Timepoint: Before starting the intervention according to evaluation access for taking out the amplatz. Method of measurement: chornometer.;Creatinine. Timepoint: Measuring the creatinine a day before starting the intervention. Method of measurement: Laboratory analyzer.;Amount of creatinine. Timepoint: Measuring creatinine a day after the intervention. Method of measurement: Laboratory analyzer.;Hemoglobin. Timepoint: On the first day after the intervention in those who have abdominal flank compression . Method of measurement: Laboratory Analyzer.;Hemoglobin. Timepoint: On the second day after the intervention in those who have abdominal flank compression . Method of measurement: Laboratory Analyzer.;Flank's compression time. Timepoint: After starting the intervention. Method of measurement: Chronometer.;Age. Timepoint: A day before the percoutaneous nephrolithotomy surgery. Method of measurement: Questionnaire.;The transfused blood. Timepoint: Before the intervention and 24 hours after the surgery. Method of measurement: 3 liters blood in one third, two thirds serum in the operating room by section nurse. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactRobab Maghsoudi
Tehran University of Medical Sciences
Outcome results
None listed